Mackenzie Financial’s Exelon EXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$27.2M Sell
582,744
-156,071
-21% -$7.22M 0.03% 376
2026
Q1
$36.2M Buy
738,815
+76,376
+12% +$3.55M 0.04% 310
2025
Q4
$29M Sell
662,439
-288,592
-30% -$13.2M 0.03% 331
2025
Q3
$42.8M Sell
951,031
-156,682
-14% -$6.88M 0.05% 272
2025
Q2
$48.1M Buy
1,107,713
+421,318
+61% +$18.8M 0.06% 235
2025
Q1
$31.6M Buy
686,395
+450,141
+191% +$18.8M 0.05% 276
2024
Q4
$8.89M Sell
236,254
-44,881
-16% -$1.74M 0.01% 487
2024
Q3
$11.4M Sell
281,135
-5,296
-2% -$199K 0.02% 423
2024
Q2
$9.91M Sell
286,431
-196,843
-41% -$7.27M 0.01% 431
2024
Q1
$18.2M Sell
483,274
-67,901
-12% -$2.43M 0.03% 347
2023
Q4
$19.8M Sell
551,175
-260,669
-32% -$10M 0.03% 342
2023
Q3
$30.1M Sell
811,844
-80,816
-9% -$3.29M 0.05% 257
2023
Q2
$36.6M Sell
892,660
-372,363
-29% -$15.4M 0.06% 248
2023
Q1
$53M Sell
1,265,023
-160,246
-11% -$6.68M 0.08% 215
2022
Q4
$61.6M Sell
1,425,269
-152,831
-10% -$6.04M 0.1% 182
2022
Q3
$59.1M Buy
1,578,100
+32,140
+2% +$1.42M 0.1% 187
2022
Q2
$70.1M Buy
1,545,960
+229,697
+17% +$10.8M 0.11% 178
2022
Q1
$62.7M Sell
1,316,263
-378,864
-22% -$16M 0.08% 206
2021
Q4
$49.8M Buy
1,695,127
+23,883
+1% +$899K 0.07% 245
2021
Q3
$57.6M Buy
1,671,244
+199,796
+14% +$6.83M 0.08% 217
2021
Q2
$46.5M Buy
1,471,448
+75,817
+5% +$2.44M 0.06% 231
2021
Q1
$43.5M Buy
1,395,631
+727,502
+109% +$21.9M 0.07% 221
2020
Q4
$20.1M Buy
668,129
+132,524
+25% +$3.91M 0.04% 257
2020
Q3
$13.7M Buy
535,605
+6,215
+1% +$165K 0.03% 262
2020
Q2
$13.7M Buy
529,390
+83,976
+19% +$2.23M 0.04% 264
2020
Q1
$11.7M Buy
445,414
+71,076
+19% +$2.24M 0.04% 262
2019
Q4
$12.2M Buy
374,338
+46,417
+14% +$1.5M 0.03% 296
2019
Q3
$11.3M Sell
327,921
-47,630
-13% -$1.6M 0.03% 315
2019
Q2
$12.8M Sell
375,551
-467,702
-55% -$16.5M 0.03% 284
2019
Q1
$30.2M Buy
843,253
+227,761
+37% +$7.76M 0.07% 226
2018
Q4
$19.8M Buy
615,492
+85,031
+16% +$2.72M 0.05% 250
2018
Q3
$16.5M Buy
530,461
+7,697
+1% +$237K 0.04% 255
2018
Q2
$15.9M Buy
522,764
+100,437
+24% +$2.88M 0.04% 253
2018
Q1
$11.8M Buy
422,327
+293,413
+228% +$7.92M 0.03% 307
2017
Q4
$3.62M Buy
128,914
+121,319
+1,597% +$3.49M 0.01% 468
2017
Q3
$204K Buy
+7,595
New +$203K ﹤0.01% 596
2017
Q1
Sell
-22,488
Closed -$569K 655
2016
Q4
$569K Buy
+22,488
New +$533K ﹤0.01% 500
2016
Q3
Sell
-170,867
Closed -$4.43M 723
2016
Q2
$4.43M Buy
170,867
+5,707
+3% +$141K 0.03% 332
2016
Q1
$4.22M Buy
165,160
+21,454
+15% +$481K 0.04% 271
2015
Q4
$2.85M Buy
143,706
+19,518
+16% +$396K 0.02% 364
2015
Q3
$2.63M Buy
124,188
+34,749
+39% +$781K 0.02% 375
2015
Q2
$2M Buy
89,439
+6,679
+8% +$160K 0.01% 427
2015
Q1
$1.98M Buy
82,760
+7,328
+10% +$182K 0.01% 428
2014
Q4
$2M Buy
75,432
+19,077
+34% +$490K 0.01% 418
2014
Q3
$1.37M Buy
56,355
+25,782
+84% +$604K 0.01% 464
2014
Q2
$796K Buy
30,573
+9,657
+46% +$246K ﹤0.01% 548
2014
Q1
$501K Buy
20,916
+5,172
+33% +$109K ﹤0.01% 585
2013
Q4
$308K Buy
15,744
+5,484
+53% +$110K ﹤0.01% 605
2013
Q3
$217K Buy
+10,260
New +$224K ﹤0.01% 606

Other funds holding EXC

Mackenzie Financial's EXC Position: Q2 2026 in Review

Mackenzie Financial reduced its Exelon (EXC) stake by 21% in Q2 2026, selling an estimated $7.22M and leaving 582,744 shares worth $27.2M. The position accounts for 0.03% of the portfolio, ranked #376.

Mackenzie Financial first reported a position in EXC in Q3 2013 and has held it in 49 quarters since. The position peaked at $70.1M in Q2 2022. 1,286 funds tracked by Wall St. Rank hold EXC as of Q2 2026.

  • Mackenzie Financial held 582,744 shares of Exelon worth $27.2M as of Q2 2026.
  • Mackenzie Financial sold 156,071 Exelon shares in Q2 2026, an estimated $7.22M.
  • Exelon made up 0.03% of Mackenzie Financial's portfolio in Q2 2026, its #376 holding.
  • Mackenzie Financial first reported a position in Exelon in Q3 2013 and has held it in 49 quarters since.
  • Mackenzie Financial's Exelon position peaked at $70.1M in Q2 2022.
  • 1,286 funds tracked by Wall St. Rank held Exelon as of Q2 2026.

Based on Mackenzie Financial's 13F filing for Q2 2026, filed 13 Aug 2026.